StonvexLoading…
StonvexStonvexStonvexCore line items from TELA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $80.28M | $69.30M | $58.45M | $41.42M |
Operating Income | $-33.76M | $-34.12M | $-44.08M | $-39.01M |
Net Income | $-38.83M | $-37.84M | $-46.66M | $-44.30M |
EPS (Diluted) | $-0.83 | $-1.33 | $-2.04 | $-2.72 |
Total Assets | $81.42M | $86.57M | $78.05M | $67.86M |
Total Liabilities | $75.11M | $58.11M | $59.17M | $53.55M |
Cash & Equivalents | $50.84M | $52.67M | $46.73M | $42.02M |
Free Cash Flow OCF − CapEx | $-28.67M | $-42.58M | $-41.47M | $-41.62M |
Shares Outstanding | 44.54M | 39.40M | 24.49M | 19.17M |